PubMed:22752006 / 1026-1233 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T7","span":{"begin":0,"end":207},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":207},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":207},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Targeted inhibition of Gal1 expression through antibody (Ab)-mediated blockade, addition of the specific disaccharide lactose or retroviral-mediated siRNA strategies prevented these immunoregulatory effects."}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T38","span":{"begin":47,"end":55},"obj":"FMAID:167180"},{"id":"_T39","span":{"begin":105,"end":117},"obj":"FMAID:196733"},{"id":"_T40","span":{"begin":105,"end":117},"obj":"FMAID:82744"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"Targeted inhibition of Gal1 expression through antibody (Ab)-mediated blockade, addition of the specific disaccharide lactose or retroviral-mediated siRNA strategies prevented these immunoregulatory effects."}

{"project":"GO-MF","denotations":[{"id":"T6","span":{"begin":47,"end":55},"obj":"http://purl.obolibrary.org/obo/GO_0003823"}],"text":"Targeted inhibition of Gal1 expression through antibody (Ab)-mediated blockade, addition of the specific disaccharide lactose or retroviral-mediated siRNA strategies prevented these immunoregulatory effects."}

{"project":"Allie","denotations":[{"id":"SS1_22752006_6_0","span":{"begin":47,"end":55},"obj":"expanded"},{"id":"SS2_22752006_6_0","span":{"begin":57,"end":59},"obj":"abbr"}],"relations":[{"id":"AE1_22752006_6_0","pred":"abbreviatedTo","subj":"SS1_22752006_6_0","obj":"SS2_22752006_6_0"}],"text":"Targeted inhibition of Gal1 expression through antibody (Ab)-mediated blockade, addition of the specific disaccharide lactose or retroviral-mediated siRNA strategies prevented these immunoregulatory effects."}

{"project":"GlyTouCan-IUPAC","denotations":[{"id":"GlycanIUPAC_T14","span":{"begin":23,"end":27},"obj":"\"http://rdf.glycoinfo.org/glycan/G32871SU\""},{"id":"GlycanIUPAC_T23","span":{"begin":23,"end":27},"obj":"\"http://rdf.glycoinfo.org/glycan/G07087RJ\""},{"id":"GlycanIUPAC_T32","span":{"begin":23,"end":27},"obj":"\"http://rdf.glycoinfo.org/glycan/G40843KY\""},{"id":"GlycanIUPAC_T41","span":{"begin":23,"end":27},"obj":"\"http://rdf.glycoinfo.org/glycan/G68158BT\""},{"id":"GlycanIUPAC_T50","span":{"begin":23,"end":27},"obj":"\"http://rdf.glycoinfo.org/glycan/G75623HL\""},{"id":"GlycanIUPAC_T59","span":{"begin":23,"end":27},"obj":"\"http://rdf.glycoinfo.org/glycan/G08908FU\""},{"id":"GlycanIUPAC_T68","span":{"begin":23,"end":27},"obj":"\"http://rdf.glycoinfo.org/glycan/G38028NH\""},{"id":"GlycanIUPAC_T77","span":{"begin":23,"end":27},"obj":"\"http://rdf.glycoinfo.org/glycan/G48426CT\""},{"id":"GlycanIUPAC_T86","span":{"begin":23,"end":27},"obj":"\"http://rdf.glycoinfo.org/glycan/G34526ZS\""},{"id":"GlycanIUPAC_T95","span":{"begin":23,"end":27},"obj":"\"http://rdf.glycoinfo.org/glycan/G25681JY\""},{"id":"GlycanIUPAC_T104","span":{"begin":23,"end":27},"obj":"\"http://rdf.glycoinfo.org/glycan/G75236KD\""}],"text":"Targeted inhibition of Gal1 expression through antibody (Ab)-mediated blockade, addition of the specific disaccharide lactose or retroviral-mediated siRNA strategies prevented these immunoregulatory effects."}

{"project":"Glycan-GlyCosmos","denotations":[{"id":"T1","span":{"begin":118,"end":125},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G15541SE"},{"id":"A2","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G15541SE"}],"text":"Targeted inhibition of Gal1 expression through antibody (Ab)-mediated blockade, addition of the specific disaccharide lactose or retroviral-mediated siRNA strategies prevented these immunoregulatory effects."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T7","span":{"begin":0,"end":207},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":207},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":207},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Targeted inhibition of Gal1 expression through antibody (Ab)-mediated blockade, addition of the specific disaccharide lactose or retroviral-mediated siRNA strategies prevented these immunoregulatory effects."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T7","span":{"begin":0,"end":207},"obj":"Sentence"}],"text":"Targeted inhibition of Gal1 expression through antibody (Ab)-mediated blockade, addition of the specific disaccharide lactose or retroviral-mediated siRNA strategies prevented these immunoregulatory effects."}

{"project":"GlyCosmos15-Glycan","denotations":[{"id":"T1","span":{"begin":118,"end":125},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G15541SE"},{"id":"A2","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G15541SE"}],"text":"Targeted inhibition of Gal1 expression through antibody (Ab)-mediated blockade, addition of the specific disaccharide lactose or retroviral-mediated siRNA strategies prevented these immunoregulatory effects."}